Manufacturers of generics have received permission to work in EU

European antitrust regulators have allowed manufacturers of generic drugs to unite for the supply of medicines in clinics for the treatment of patients with coronavirus. About it reports Reuters.

This measure was the final step in the direction of simplification the strict Antimonopoly regulation in the EU, which should help in the fight against the pandemic. Regulators said that the rejection of the previously approved rules will allow to avoid deficiency of essential generic drugs.

“In the current environment, a temporary partnership of pharmaceutical companies seems to be justified”, – reads the statement of the regulators.

Leave a Reply

Your email address will not be published. Required fields are marked *


For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]